StockDrifts LogoStockDrifts

Rhenman & Partners Asset Management AB 13F Portfolio

Portfolio Manager
Rhenman & Partners Asset Management AB
Performance
+3.82% (2026 Q2)
AUM (13F)
$1.06B
# of Holdings
99
Performance Rank
Allocation (Top 20)
42.01%
Latest filing
Q2 2026

Rhenman & Partners Asset Management AB Holdings Map

Top 50 Rhenman & Partners Asset Management AB Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
UNH
UNITED HEALTH GROUP INC
3.67%93.6K$38.9M
+105.71%(+48.10K)
2025-Q2: 30.4K shares2025-Q3: 62.5K shares2025-Q4: 54.9K shares2026-Q1: 45.5K shares2026-Q2: 93.6K shares
$366.24(+8.26%)
2026-06-30
CVS
CVS HEALTH CORP
2.73%279.4K$28.9M
-16.98%(-57.13K)
2025-Q2: 295.4K shares2025-Q3: 277.4K shares2025-Q4: 335.5K shares2026-Q1: 336.5K shares2026-Q2: 279.4K shares
$67.68(+43.56%)
2026-06-30
AZN
ASTRAZENECA PLC
2.69%151.5K$28.5Mnew2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 0 shares2026-Q2: 151.5K shares
$191.75(-18.39%)
2026-06-30
MRK
MERCK & CO INC
2.59%213.5K$27.4Mnew2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 0 shares2026-Q2: 213.5K shares
$119.40(+14.09%)
2026-06-30
LLY
LILLY ELI & CO
2.53%22.3K$26.8M
-33.81%(-11.40K)
2025-Q2: 57.9K shares2025-Q3: 53.4K shares2025-Q4: 42.2K shares2026-Q1: 33.7K shares2026-Q2: 22.3K shares
$396.25(+197.63%)
2026-06-30
ABBV
ABBVIE INC
2.3%96.8K$24.4M
+35.21%(+25.20K)
2025-Q2: 69.4K shares2025-Q3: 130.4K shares2025-Q4: 110.6K shares2026-Q1: 71.6K shares2026-Q2: 96.8K shares
$176.34(+41.44%)
2026-06-30
ALHC
ALIGNMENT HEALTHCARE INC
2.24%997.1K$23.7M
-5.35%(-56.37K)
2025-Q2: 1.29M shares2025-Q3: 1.48M shares2025-Q4: 1.01M shares2026-Q1: 1.05M shares2026-Q2: 997.1K shares
$9.64(+40.80%)
2026-06-30
EW
EDWARDS LIFESCIENCES CORP
2.22%260.0K$23.5M
+59.51%(+97.00K)
2025-Q2: 55.0K shares2025-Q3: 155.0K shares2025-Q4: 193.5K shares2026-Q1: 163.0K shares2026-Q2: 260.0K shares
$82.86(+10.55%)
2026-06-30
GILD
GILEAD SCIENCES INC
2.13%178.3K$22.5M
+6.26%(+10.50K)
2025-Q2: 168.2K shares2025-Q3: 80.2K shares2025-Q4: 126.2K shares2026-Q1: 167.8K shares2026-Q2: 178.3K shares
$100.87(+37.16%)
2026-06-30
JAZZ
JAZZ PHARMACEUTICALS PLC
1.99%87.4K$21.1M
+15.22%(+11.55K)
2025-Q2: 109.0K shares2025-Q3: 95.0K shares2025-Q4: 74.0K shares2026-Q1: 75.9K shares2026-Q2: 87.4K shares
$144.48(+70.12%)
2026-06-30

About Rhenman & Partners Asset Management ABโ€™s portfolio

Rhenman & Partners Asset Management AB reports $1.06B in US-listed equity holdings across 99 positions in its most recent 13F filing. Its largest disclosed positions are UNH (3.7%), CVS (2.7%) and AZN (2.7%). The top 20 holdings account for 42.01% of reported assets. Its disclosed equity book has returned +28.05% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.

Portfolio concentration

Portfolio concentration
UNH โ€” 4.6% ($38.90M)CVS โ€” 3.4% ($28.90M)AZN โ€” 3.4% ($28.48M)MRK โ€” 3.3% ($27.43M)LLY โ€” 3.2% ($26.77M)ABBV โ€” 2.9% ($24.35M)ALHC โ€” 2.8% ($23.74M)EW โ€” 2.8% ($23.52M)GILD โ€” 2.7% ($22.52M)JAZZ โ€” 2.5% ($21.07M)Other โ€” 68.3% ($572.43M)
32%in top 10
  • UNH4.6%
  • CVS3.4%
  • AZN3.4%
  • MRK3.3%
  • LLY3.2%
  • ABBV2.9%
  • ALHC2.8%
  • EW2.8%
  • GILD2.7%
  • JAZZ2.5%
  • Other68.3%

Portfolio changes

What the fund actually did

Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.

New buys
6
AZNASTRAZENECA PLC2.7%
MRKMERCK & CO INC2.6%
JNJJOHNSON & JOHNSON1.7%
CNCCENTENE CORP DEL1.5%
+2 opened
Added to
26
UNHUNITED HEALTH GROUP INC+105.7%
DHRDANAHER CORPORATION+344.6%
ALGNALIGN TECHNOLOGY INC+740.0%
NRIXNURIX THERAPEUTICS INC+118.3%
+22 more
Trimmed
18
LLYLILLY ELI & CO-33.8%
REGNREGENERON PHARMACEUTICALS-43.1%
OSCROSCAR HEALTH INC-40.6%
BSXBOSTON SCIENTIFIC CORP-27.9%
+14 more

Unlock alerts, watchlists & AI chat

Sign up free to track Rhenman & Partners Asset Management AB, compare funds side by side, and get alerts the moment positions change.

Source filings

Holdings on this page are parsed from Rhenman & Partners Asset Management ABโ€™s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1599882). View Rhenman & Partners Asset Management ABโ€™s 13F filings on SEC

More 13F analyses

View all